A 52-year-old patient with a serum 25‑hydroxyvitamin D level that increased from 23 ng/mL to 42.8 ng/mL after oral vitamin D supplementation—should the supplement be discontinued?

No, She Should Not Stop—Continue Maintenance Vitamin D Supplementation

Your patient's vitamin D level of 42.8 ng/mL is in the optimal therapeutic range (30-50 ng/mL), and she should continue maintenance supplementation at 800-1000 IU daily to sustain this level, not discontinue it entirely. 1, 2

Why Continuation is Recommended

At age 52, your patient falls into the category where ongoing vitamin D maintenance is beneficial for bone health and fall prevention. Her current level of 42.8 ng/mL sits comfortably within the target range of 30-50 ng/mL recommended by multiple guidelines 1. The evidence shows no additional benefits above 50 ng/mL, and levels between 30-44 ng/mL provide optimal outcomes without increased risk 1.

Specific Management Strategy

Reduce to maintenance dosing:

• Decrease from her current corrective dose to 800-1000 IU daily 1, 2
• This maintenance dose prevents regression back to deficiency (her baseline of 23 ng/mL)
• The guideline consensus strongly supports this approach for adults over 50 (agreement score: 4.2) 1

Safety Considerations

Her current level of 42.8 ng/mL is well below any safety concerns:

• The upper safety limit is 100 ng/mL 1
• Hypercalcemia only occurs with levels exceeding 100 ng/mL or daily doses above 100,000 IU 1
• Even levels of 70-80 ng/mL are considered absolutely safe, though doses are typically reduced at that point 1
• Recent research confirms that 83.7% of patients with levels above 88 ng/mL remained normocalcemic 3

Common Pitfall to Avoid

Do not completely discontinue supplementation. Without maintenance therapy, her level will gradually decline back toward deficiency over months. The rule of thumb is that 1000 IU daily raises 25(OH)D by approximately 10 ng/mL 1, meaning cessation would likely return her to insufficient levels within 3-6 months.

Monitoring Plan

• Recheck 25(OH)D level in 3-6 months to confirm the maintenance dose is adequate 1
• If the level drops below 30 ng/mL, increase to 1600-2000 IU daily
• If the level exceeds 70 ng/mL, reduce the dose slightly 1
• No routine monitoring is needed once stable levels are confirmed 4

The 2024 Endocrine Society guidelines suggest against routine supplementation beyond DRI for adults under 50 5, but your patient at 52 years old with documented prior deficiency represents a different clinical scenario where maintenance is appropriate to prevent recurrence and optimize bone health outcomes.